Home Your basket
• Functional comparison of ...
   Price 14.00 €
• Medicamentous toxic heari...
   Price 5.50 €
• Laryngeal sarcoidosis: Ca...
   Price 5.50 €
• Complete branchial cleft ...
   Price 5.50 €
• Usefulness and limitation...
   Price 10.50 €
• Primary nasal tuberculosi...
   Price 5.50 €
• The verrucous laryngeal c...
   Price 5.50 €
• Cholesterol granuloma of ...
   Price 8.50 €
• Interstitial brachytherap...
   Price 8.50 €
• Evolution of the otology ...
   Price 5.50 €
• Chondrocalcinosis of the ...
   Price 8.50 €
• The outcome of treatments...
   Price 10.50 €
• A clinical respiratory ev...
   Price 10.50 €
• Rare benin tumors of the ...
   Price 5.50 €
• Diagnosis of non organic ...
   Price 8.50 €
• Pyogenic granuloma of the...
   Price 8.50 €
• A histopathologic evaluat...
   Price 8.50 €
• Migrant foreign body of t...
   Price 10.50 €
• Surgical management of pa...
   Price 10.50 €
• Prospective evaluation of...
   Price 10.50 €
• Retrosigmoid vestibular n...
   Price 5.50 €
• Disability in patients wi...
   Price 10.50 €
• CT scan, MR imaging and a...
   Price 10.50 €
• Implication of mitochondr...
   Price 10.50 €
• Aesthetic augmentation of...
   Price 10.50 €
• Life after total laryngec...
   Price 8.50 €
• Choanal atresia: therapeu...
   Price 10.50 €
• Smile "forced" smile vers...
   Price 10.50 €
• The prevention of voice d...
   Price 10.50 €
• Diffuse cervical cellulit...
   Price 10.50 €
• A case of nasal NK/T cell...
   Price 5.50 €
• Overlay versus underlay t...
   Price 10.50 €
• Adenoid cystic carcinoma ...
   Price 10.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €

Total Order 296.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 5 - 2003 o

PHONIATRICS

Voice prostheses: long-term follow-up retrospective study (three- to sixteen-year follow-up of 22 patients)


Authors : C. Trussart, G. Lawson, M. Remacle (Yvoir)

Ref. : Rev Laryngol Otol Rhinol. 2003;124,5:299-304.

Article published in english
Downloadable PDF document english



Summary : Background: Thirty-five patients using tracheoesophageal voice with a 3- to 16-year follow-up were investigated. We analyzed functional voice outcome, voice prosthesis (VP) lifespan, and VP-related complications. Methods: Between 1987 and 2001, 81 patients underwent total laryngectomy (TL). The 35 currently surviving patients (31 men, 4 women) were studied for VP lifespan and VP-related complications encountered up to 16 years after surgery. For voice rehabilitation, the 35 laryngectomies of our study required 178 prostheses. Short- and long-term voice results of 22 patients were compared by objective voice examination: maximum phonation time (MPT), intensity range (Int.), fundamental frequency (F0), frequency analysis (FA), and voice handicap index (VHI). Results: Long-term results are: F0=131 (range: 30-250); Int=22.5 dB (range: 17-35 dB); MPT=4sec (range: 2-12 sec); FA=3 (range: 1-4); VHI=38/120 (range: 8-73). Short- vs long-term outcome comparison shows the following values: F0: 93 vs 135 Hz; Int: 25 vs 24 dB; FA: 1 vs 3; and MPT: 21 vs 4 sec. The mean VP lifespan is 165.5 days for Provox (range: 2 days-30 months); 143.5 days for Blom-Singer (range: 10 days-24 months); and 195 days for VoiceMaster (6-7 months). Postoperative complications involved 12 cases of periprosthetic leakage (6.74%); 31 granulomas (17.4%); 3 partial stenoses of the tracheoesophageal tract (1.6%); and 1 temporarily removed VP (0.5%). Conclusions: Complications are generally resolved during standard office-setting examination. The commercially available VPs are complementary, used according to the diverse characteristics of each VP.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE